Cargando…
Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease
The development of disease-modifying drugs and differential diagnostic agents is an urgent medical need in Parkinson’s disease. Despite the complex pathophysiological pathway, the misfolding of alpha-synuclein has been identified as a putative biomarker for detecting the onset and progression of the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281355/ https://www.ncbi.nlm.nih.gov/pubmed/35831620 http://dx.doi.org/10.1007/s00415-022-11267-9 |